JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2007, 56(3):135-140

Examination of the antioxidative and antidiabetic effect of pomiferin in alloxan-induced diabetes mellitus in an experiment (a pilot study)

L. Bartošíková1, J. Nečas1, T. Bartošík2, M. Pavlík2, J. Fráňová3, G. Kuzmina1, J. Luža1
1 Lékařská fakulta Univerzita Palackého v Olomouci, Ústav fyziologie
2 Fakultní nemocnice U svaté Anny v Brně, Anesteziologicko-resuscitační klinika
3 Fakultní nemocnice Brno, Dětská nemocnice, II. dětská klinika

The antioxidative and antidiabetic effect of pomiferin was monitored under the experimental conditions of alloxan-induced diabetes mellitus. The animals were divided by random selection into 2 groups (n=7). The treated group was administered pomiferin in peroral doses of 10 mg/kg in Avicel, the placebo group was given only a solution of Avicel, and the last group was intact. Selected laboratory parameters (glucose, urea, cholesterol, antioxidative enzymes, total antioxidative capacity, malondialdehyde in serum; diuresis, total glucose and protein losses through urine) were determined. Kidney tissue and pancreas samples were taken for histopathological analysis. The findings included a statistically significant decrease (p≤0.01) in blood glucose level, a significant increase (p≤0.01) in glutathione peroxidase, total antioxidative capacity (p≤0.05) and a significant decrease (p≤0.01) in malondialdehyde level in the treated group compared to the placebo group. A highly significant decrease (p≤0.01) in diuresis, glucose and protein losses through urine were identified in the treated group compared to the placebo group. The superoxide dismutase catalytic activity, urea and cholesterol levels involved nonsignificant changes. The results of biochemical examination show a protective antioxidative and antidiabetic effect of pomiferin. The results of histopathological examination correlate with them only partially.

Keywords: pomiferin; diabetes mellitus; antioxidant

Received: March 23, 2007; Accepted: May 11, 2007; Published: March 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartošíková L, Nečas J, Bartošík T, Pavlík M, Fráňová J, Kuzmina G, Luža J. Examination of the antioxidative and antidiabetic effect of pomiferin in alloxan-induced diabetes mellitus in an experiment (a pilot study). Čes. slov. farm. 2007;56(3):135-140.
Download citation

References

  1. Yahia, R. B., Lichnovská, R., Brychta, T.: Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 2005; 149, 237-241. Go to original source...
  2. Wolff, S. P.: British Med. Bull., 1993; 49, 642-652. Go to original source... Go to PubMed...
  3. Tang, L., Wei, W., Chen, L., Liu, S.: J. Ethnopharmacol., 2006; 108, 109-115. Go to original source... Go to PubMed...
  4. Zanatta, L., de Sousa, E., Cazarolli, L. H. et al.: J. Ethnopharmacol., 2007; 109, 151-155. Go to original source... Go to PubMed...
  5. Malaisse, W. J.: Biochem. Pharmacol., 1982; 22, 35273534.
  6. Holeček, V., Racek, J.: Klin. Biochem. Metab., 1994; 2, 137-141.
  7. Nečas, J., Bartošíková, L., Drápelová, L. et al.: Vnitř. Lék., 1997; 43, 707-711.
  8. Bartošíková, L., Nečas, J., Pavlíček, V. et al.: Cs. Slov. Farm., 1998; 47, 151-154.
  9. Calomme, M., Pieters, L., Vlietinck, A., Vanden Berghe, D.:: Planta Med., 1996; 62, 222-226. Go to original source... Go to PubMed...
  10. Read, M. A.:: Am. J. Pathol., 1995; 147, 235-237. Go to original source...
  11. Perez, R. M., Zaval, M. A., Perez, S., Perez, C.: Phytomed., 1998; 5, 55-57.
  12. Jovanovic, S. V., Steenken, S., Tosic, M. et al.: J. Am. Chem. Soc., 1994; 116, 4846-4851. Go to original source...
  13. Rice-Evans, C. A., Miller, N. J., Bolwell et al.: Free. Rad. Res., 1995; 22, 375-383. Go to original source... Go to PubMed...
  14. Catapano, A. L.: Angiol., 1997; 48, 39-44.
  15. Veselá, D., Kubínová, R., Muselík, J. et al.: Fitoterapia, 2003; 75, 2029-211.
  16. Bartošíková, L., Nečas, J., Suchý, V. et al: Jahrestagung-Joint Meeting 2004, Regensburg, SRN, October 6-9, 2004 (Abstract In: ISBN: 3-00-014723-3)
  17. Kosugy, H., Kikugava, K.: Free Rad. Biol. Med., 1989; 7, 205-207.
  18. Sharma, S. B., Nasir, A., Prabhu, K. M., Murthy, P. S.: J. Ethnopharmacol., 2006; 104, 367-373. Go to original source... Go to PubMed...
  19. Sinclair, A. J.: Diabet. Rev., 1993; 2, 7-11.
  20. Giugliano, D., Ceriello, A., Paoliso, G.: Diabet, Care, 1996; 19, 257-267. Go to original source... Go to PubMed...
  21. Packer, L., Witt, E. H., Tritschler, H. J.: Biol. Med., 1995; 19, 227-250. Go to original source... Go to PubMed...
  22. Wohaieb, S. A., Godin, D. V.: Diabetes, 1987; 36, 10141018. Go to original source...
  23. Klener, P. et al.: Vnitř. Lék., 1. vyd. Praha, Galén, 1999, s. 725
  24. Roy, S., Seghal, R., Padhy, B. M., Kumar, V. L.: J. Ethnopharmacol., 2005; 102, 470-473. Go to original source... Go to PubMed...
  25. Machartová, V., Racek, J., Kohout, J. et al.: Vnitř. Lék., 2000; 46, 444-446.
  26. Stone, K. J., Willis, A. L., Hart, W. M. et al.: Lipids, 1979; 14, 174-180. Go to original source... Go to PubMed...
  27. Siguel, E. N.: Nutr. Cancor, 1983; 4, 285-291. Go to original source... Go to PubMed...
  28. Nishina, P. M., Schneeman, B. O., Freedland, R. A.: J. Nutr., 1991; 121, 431-437. Go to original source... Go to PubMed...
  29. Sharma, R. D.: Lipids, 1979; 14, 535-540. Go to original source... Go to PubMed...
  30. John, W., Loechleiter, F., Weber, F.: J. Lipid. Res., 1988; 29, 1359-1366. Go to original source...
  31. Anděl, M. et al.: Diabetes mellitus. 1. vyd. Praha, Galén, 2001, s. 78.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.